CMS issued its proposed rule for next year's Medicare physician fee schedule, revealing plans to cut payment rates by 2.8%. Industry groups swiftly expressed their outrage, arguing that reimbursement rates need to keep up with the pace of inflation.
The healthcare landscape is undergoing a significant transformation, with health information exchanges (HIEs) and health data utilities (HDUs) playing a pivotal role in facilitating the secure exchange of patient data.
Velatura, a leading multi-jurisdictional health information exchange and health data utility, along with Docusign, to streamline the process of obtaining and managing informed patient consent.
Join us for INVEST Digital Health at Pegasus Park in Dallas on September 18, and engage with a remarkable lineup of speakers. Gain first-hand knowledge and unique perspectives from industry leaders and visionaries in their respective fields.
By attending you not only gain knowledge and inspiration, but also build valuable connections and uncover opportunities to propel your personal and professional growth.
Unlike GLP-1 agonist drugs marketed for weight loss, new Amylyx Pharmaceuticals drug avexitide blocks its target receptor. Amylyx plans to advance this GLP-1 antagonist into Phase 3 testing for post-bariatric hypoglycemia, a rare condition in which blood sugar levels drop precipitously.
Rick Ratliff, a pharmacy industry veteran who was for a time CEO of Surescripts, built a national digital prescription network connecting doctors to pharmacies.
No comments